Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
J Immunol. 2013 Apr 15;190(8):3831-8. doi: 10.4049/jimmunol.1203487.
Although acute or chronic inflammation is a common component of many clinical disorders, the underlying processes can be highly distinct. In recent years, the complement system has been associated with a growing number of immunological and inflammatory conditions that include degenerative diseases, cancer, and transplant rejection. It becomes evident that excessive activation or insufficient control of complement activation on host cells can cause an immune imbalance that may fuel a vicious cycle between complement, inflammatory cells, and tissue damage that exacerbates clinical complications. Although the exact involvement of complement needs to be carefully investigated for each disease, therapeutic modulation of complement activity emerges as an attractive target for upstream inhibition of inflammatory processes. This review provides an update about the functional and collaborative capabilities of complement, highlights major disease areas with known complement contribution, and indicates the potential for complement as a focal point in immunomodulatory strategies for treating inflammatory diseases.
虽然急性或慢性炎症是许多临床疾病的常见组成部分,但潜在的过程可能高度不同。近年来,补体系统与越来越多的免疫和炎症性疾病相关联,包括退行性疾病、癌症和移植排斥。很明显,补体对宿主细胞的过度激活或控制不足会导致免疫失衡,从而加剧补体、炎症细胞和组织损伤之间的恶性循环,加重临床并发症。尽管需要仔细研究每种疾病中补体的确切参与,但补体活性的治疗调节作为炎症过程上游抑制的有吸引力的靶点出现。本文综述了补体的功能和协同作用能力,强调了已知补体参与的主要疾病领域,并指出补体作为治疗炎症性疾病的免疫调节策略的焦点的潜力。